Loading…
Detection of serum 25(OH)-vitamin D level in the serum of women with fibromyalgia syndrome and its relation to pain severity
Objective The aim of our study is to determine serum 25(OH)-vitamin D level in patients with fibromyalgia syndrome and its relation to pain. Patients and methods Fifty-three women with fibromyalgia syndrome diagnosed according to the American College of Rheumatology 1990 fibromyalgia diagnostic crit...
Saved in:
Published in: | Egyptian Rheumatology and Rehabilitation 2015-10, Vol.42 (4), p.196-200 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective
The aim of our study is to determine serum 25(OH)-vitamin D level in patients with fibromyalgia
syndrome and its relation to pain.
Patients and methods
Fifty-three women with fibromyalgia syndrome diagnosed according to the American College
of Rheumatology 1990 fibromyalgia diagnostic criteria and 50 age-matched healthy women as
a control group were included in this study. Serum 25(OH)-vitamin D levels were determined
in both the patient and the control groups. Fibromyalgia Impact Questionnaire scores and pain
intensity measured by the visual analogue scale were evaluated.
Results
We found a statistically significant decrease in serum vitamin D level in the patient group in
comparison with the control group. There was a significant negative correlation (P = 0.000)
between vitamin D level and Fibromyalgia Impact Questionnaire. The same results are found
between vitamin D level and visual analogue scale. There was no significant correlation between
vitamin D level and erythrocyte sedimentation rate or C-reactive protein.
Conclusion
We found a significant association between fibromyalgia and low 25(OH)-vitamin D levels
as suggested previously in other studies. Also, there was a correlation between the level of
vitamin D in serum and severity of pain. We recommend vitamin D screening in every patient
with chronic nonspecific musculoskeletal pain, especially fibromyalgia, and extended research
in this area with large numbers of patients. |
---|---|
ISSN: | 1110-161X 2090-3235 |
DOI: | 10.4103/1110-161X.168202 |